Study suggests Pfizer/BioNTech vaccine effective against Covid-19 variants
New research suggests that Pfizer/BioNTech’s mRNA Covid-19 vaccine, BNT162b2, protects against two variants of SARS-CoV-2,...
UK approves Moderna’s mRNA Covid-19 vaccine for emergency use
The UK’s healthcare regulator the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Moderna’s mRNA...
ImmunityBio and Microsoft create 3D model to support Covid-19 research
Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create...
Exscientia forms UK-US partnership to screen possible Covid-19 drugs
Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with...
Noveome studies anti-inflammatory drug ST266 in Covid-19
Next generation biologics company Noveome Biotherapeutics will evaluate its lead programme ST266 as a potential...
J&J partners with BARDA to commit $1bn to Covid-19 vaccine development
Johnson & Johnson (J&J) has expanded its partnership with the US Department for Health and...
UK pledges £210m to CEPI for Covid-19 vaccine development
Non-profit the Coalition for Epidemic Preparedness Innovations (CEPI) has received £210m from the UK Government...
Novavax’s Nanoflu compares well to Fluzone Quadrivalent
US-based Novavax has published top-line Phase III data for its seasonal influenza vaccine Nanoflu in...